Newsbenzinga
MetaVia Reports Up To 9.1% Weight Loss In Phase 1 DA-1726 Study, Showcases Combination Data For Metabolic Disease Programs At ADA 2026
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…